This market refers to the table tennis match between Holub Martin and Moulis Pavel in Setka Cup Czechia Men, scheduled for August 28 at 7:00AM ET.
This market will resolve to 'Holub Martin' if Holub Martin wins against Moulis Pavel.
This market will resolve to 'Moulis Pavel' if Moulis Pavel wins against Holub Martin.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one player advances due to the opponent's retirement, default, or disqualification, this market will resolve to the player who advances.
If the match ends in a walkover (player withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source for this market is the official statistics of the event as recognized by the governing body or event organizers. However, if the governing body or event organizers have not published final match statistics within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead.
Holub Martin vs. Moulis Pavel
Game context
Martin Holub and Pavel Moulis compete regularly in the Setka Cup and Czech Liga Pro table tennis events, where matches typically run best of five sets with frequent deuces and extended rallies. Holub enters with solid recent form, posting a 13-7 record in his last 20 outings and strong point totals averaging near 75 per match, often prevailing in straight sets or split first-two-game scenarios against mid-tier opponents like Vaclav Coubal and Jan Vrnak. Moulis has shown inconsistency, alternating wins and losses in high-volume schedules with results frequently decided in four or five sets against similar competition. Head-to-head patterns in the circuit favor players maintaining service-point efficiency and adapting to varying pace, while short turnaround times between daily fixtures and minor fatigue from back-to-back play can shift momentum. No major roster or eligibility issues affect
